Foghorn Therapeutics Inc.
Biotechnology ResearchView the employees at
Foghorn Therapeutics Inc.-
Silvia Escudero Principal Scientist at Foghorn Therapeutics, Inc
-
Boston, Massachusetts, United States
-
Top 5%
Alena Reva Senior Director, People Operations and Total Rewards at Foghorn Therapeutics| Design Thinking, People Experience and Data| Global Citizen| Autism Mom-
Greater Boston
-
Top 10%
Breanna Bullock Research Associate at Foghorn Therapeutics-
Rising Star
Kevin Wilson VP, Head of Chemistry at Foghorn Therapeutics, Inc-
Greater Boston
-
Rising Star
Anais Gervais, Ph.D. Director, Business and Commercial Strategy at Foghorn Therapeutics-
Greater Boston
-
Top 5%
Overview
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.
-